{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T02:53:17Z","timestamp":1761706397998,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":45,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493987955"},{"type":"electronic","value":"9781493987962"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-8796-2_16","type":"book-chapter","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T16:59:43Z","timestamp":1549472383000},"page":"211-229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Safety and Toxicity of Recombinant Methioninase and Polyethylene Glycol (PEG) Recombinant Methioninase in Primates"],"prefix":"10.1007","author":[{"given":"Robert M.","family":"Hoffman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shukuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1517\/14712598.2015.963050","volume":"15","author":"RM Hoffman","year":"2015","unstructured":"Hoffman RM (2015) Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40-year odyssey. Expert Opin Biol Ther 15:21\u201331","journal-title":"Expert Opin Biol Ther"},{"key":"16_CR2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.18632\/oncotarget.23185","volume":"9","author":"K Kawaguchi","year":"2018","unstructured":"Kawaguchi K, Igarashi K, Li S, Han Q, Tan Y, Miyake K, Kiyuna T, Miyake M, Murakami T, Chmielowski S, Nelson SD, Russell TA, Dry SM, Li Y, Unno M, Eilber FC, Hoffman RM (2018) Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models. Oncotarget 9:915\u2013923","journal-title":"Oncotarget"},{"issue":"3","key":"16_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/15384101.2017.1405195","volume":"17","author":"K Kawaguchi","year":"2018","unstructured":"Kawaguchi K, Han Q, Li S, Tan Y, Igarashi K, Kiyuna T, Miyake K, Miyake M, Chmielowski B, Nelson SD, Russell TA, Dry SM, Li Y, Eckhardt MA, Unno M, Eilber FC, Hoffman RM (2018) Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for clinical cancer therapy and prevention. Cell Cycle 17(3):356\u2013361","journal-title":"Cell Cycle"},{"key":"16_CR4","first-page":"1","volume":"21","author":"K Kawaguchi","year":"2018","unstructured":"Kawaguchi K, Miyake K, Han Q, Li S, Tan Y, Igarashi K, Lwin TM, Higuchi T, Kiyuna T, Miyake M, Oshiro H, Bouvet M, Unno M, Hoffman RM (2018) Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer. Cell Cycle 21:1\u20136","journal-title":"Cell Cycle"},{"key":"16_CR5","first-page":"1862","volume":"33","author":"W Kreis","year":"1973","unstructured":"Kreis W, Hession C (1973) Isolation and purification of L-methionine-alpha-deamino-gamma-mercaptomethane-lyase (L-methioninase) from Clostridium sporogenes. Cancer Res 33:1862\u20131865","journal-title":"Cancer Res"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1021\/bi00620a016","volume":"16","author":"H Tanaka","year":"1977","unstructured":"Tanaka H, Esaki N, Soda K (1977) Properties of L-methionine g-lyase from Pseudomonas ovalis. Biochemistry 16:100\u2013106","journal-title":"Biochemistry"},{"key":"16_CR7","first-page":"2116","volume":"56","author":"H Hori","year":"1996","unstructured":"Hori H, Takabayashi K, Orvis L, Carson DA, Nobori T (1996) Gene cloning and characterization of Pseudomonas putida L-methionine \u03b1-deamino-\u03b3-mercaptomethanelyase. Cancer Res 56:2116\u20132122","journal-title":"Cancer Res"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1006\/prep.1996.0700","volume":"9","author":"Y Tan","year":"1997","unstructured":"Tan Y, Xu M, Tan X-Z, Tan X-Y, Wang X, Saikawa Y, Nagahama T, Sun X, Lenz M, Hoffman RM (1997) Overexpression and large-scale production of recombinant l-methionine-\u03b1-deamino-\u03b3-mercaptomethane-lyase for novel anticancer therapy. Protein Expr Purif 9:233\u2013245","journal-title":"Protein Expr Purif"},{"key":"16_CR9","first-page":"2157","volume":"5","author":"Y Tan","year":"1999","unstructured":"Tan Y, Sun X, Xu M, Tan X-Z, Sasson A, Rashidi B, Han Q, Tan X-Y, Wang X, An Z, Sun F-X, Hoffman RM (1999) Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice. Clin Cancer Res 5:2157\u20132163","journal-title":"Clin Cancer Res"},{"key":"16_CR10","first-page":"2583","volume":"58","author":"T Yoshioka","year":"1998","unstructured":"Yoshioka T, Wada T, Uchida N, Maki H, Yoshida H, Ide N, Kasai H, Hojo K, Shono K, Maekawa R, Yagi S, Hoffman RM, Sugita K (1998) Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase. Cancer Res 58:2583\u20132587","journal-title":"Cancer Res"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/01635589709514624","volume":"29","author":"DM Kokkinakis","year":"1997","unstructured":"Kokkinakis DM, Schold SC Jr, Hori H, Nobori T (1997) Effect of long-term depletion of plasma methionine on the growth and survival of human brain tumor xenografts in athymic mice. Nutr Cancer 29:195\u2013204","journal-title":"Nutr Cancer"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1021\/tx020033n","volume":"15","author":"DM Kokkinakis","year":"2002","unstructured":"Kokkinakis DM, Wick JB, Zhou Q-X (2002) Metabolic response of normal and malignant tissue to acute and chronic methionine stress in athymic mice bearing human glial tumor xenografts. Chem Res Toxicol 15:1472\u20131479","journal-title":"Chem Res Toxicol"},{"key":"16_CR13","doi-asserted-by":"crossref","first-page":"35630","DOI":"10.18632\/oncotarget.15823","volume":"8","author":"T Murakami","year":"2017","unstructured":"Murakami T, Li S, Han Q, Tan Y, Kiyuna T, Igarashi K, Kawaguchi K, Hwang HK, Miyaki K, Singh AS, Nelson SD, Dry SM, Li Y, Hiroshima Y, Lwin TM, DeLong JC, Chishima T, Tanaka K, Bouvet M, Endo I, Eilber FC, Hoffman RM (2017) Recombinant methioninase effectively targets a Ewing\u2019s sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model. Oncotarget 8:35630\u201335638","journal-title":"Oncotarget"},{"key":"16_CR14","doi-asserted-by":"crossref","first-page":"85516","DOI":"10.18632\/oncotarget.20231","volume":"8","author":"K Kawaguchi","year":"2017","unstructured":"Kawaguchi K, Igarashi K, Li S, Han Q, Tan Y, Kiyuna T, Miyake Y, Murakami T, Chmielowski B, Nelson SD, Russell TA, Dry SM, Li Y, Unno M, Eilber FC, Hoffman RM (2017) Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma growth in a patient-derived orthotopic xenograft. Oncotarget 8:85516\u201385525","journal-title":"Oncotarget"},{"key":"16_CR15","first-page":"3937","volume":"16","author":"Y Tan","year":"1996","unstructured":"Tan Y, Zavala J Sr, Xu M, Zavala J Jr, Hoffman RM (1996) Serum methionine depletion without side effects by methioninase in metastatic breast cancer patients. Anticancer Res 16:3937\u20133942","journal-title":"Anticancer Res"},{"key":"16_CR16","first-page":"3857","volume":"17","author":"Y Tan","year":"1997","unstructured":"Tan Y, Zavala J Sr, Han Q, Xu M, Sun X, Tan X-Z, Tan X-Y, Magana R, Geller J, Hoffman RM (1997) Recombinant methioninase infusion reduces the biochemical endpoint of serum methionine with minimal toxicity in high-stage cancer patients. Anticancer Res 17:3857\u20133860","journal-title":"Anticancer Res"},{"key":"16_CR17","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1158\/1078-0432.CCR-03-0068","volume":"10","author":"Z Yang","year":"2004","unstructured":"Yang Z, Wang J, Yoshioka T, Li B, Lu Q, Li S, Sun X, Tan Y, Yagi S, Frenkel EP, Hoffman RM (2004) Pharmacokinetics, methionine depletion, and antigenicity of recombinant methioninase in primates. Clin Cancer Res 10:2131\u20132138","journal-title":"Clin Cancer Res"},{"key":"16_CR18","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.1158\/0008-5472.CAN-04-1822","volume":"64","author":"Z Yang","year":"2004","unstructured":"Yang Z, Wang J, Lu Q, Xu J, Kobayashi Y, Takakura T, Takimoto A, Yoshioka T, Lian C, Chen C, Zhang D, Zhang Y, Li S, Sun X, Tan Y, Yagi S, Frenkel EP, Hoffman RM (2004) PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates. Cancer Res 64:6673\u20136678","journal-title":"Cancer Res"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0168-3659(01)00277-2","volume":"72","author":"A Kozlowski","year":"2001","unstructured":"Kozlowski A, Harris JM (2001) Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C. J Control Release 72:217\u2013224","journal-title":"J Control Release"},{"key":"16_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/b105364","volume-title":"Advances in experimental medicine and biology: polymer drugs in the clinical stage","author":"H Maeda","year":"2003","unstructured":"Maeda H, Kabanov A, Kataska K, Okano T (2003) Advances in experimental medicine and biology: polymer drugs in the clinical stage, vol 519. Kluwer Academic\/Plenum Publishers, Dordrecht"},{"key":"16_CR21","unstructured":"Park CWG, Chuo M Interferon polymer conjugates. United States Patent 5,951,974, September 14, 1999"},{"key":"16_CR22","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1203::AID-CNCR15>3.0.CO;2-3","volume":"86","author":"A Aguayo","year":"1999","unstructured":"Aguayo A, Cortes J, Thomas D, Pierce S, Keating M, Kantarjian H (1999) Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia. Cancer 86:1203\u20131209","journal-title":"Cancer"},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1126\/science.2326644","volume":"248","author":"R Pool","year":"1990","unstructured":"Pool R (1990) \u201cHairy enzymes\u201d stay in the blood. Science 248:305","journal-title":"Science"},{"key":"16_CR24","doi-asserted-by":"publisher","first-page":"S228","DOI":"10.1016\/S0090-1229(95)90306-2","volume":"76","author":"MS Hershfield","year":"1995","unstructured":"Hershfield MS (1995) PEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years. Clin Immunol Immunopathol 76:S228\u2013S232","journal-title":"Clin Immunol Immunopathol"},{"key":"16_CR25","first-page":"8377","volume":"63","author":"X Sun","year":"2003","unstructured":"Sun X, Yang Z, Li S, Tan Y, Zhang N, Wang X, Yagi S, Yoshioka T, Takimoto A, Mitsushima K, Suginaka A, Frenkel EP, Hoffman RM (2003) In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5\u2032 phosphate supplementation. Cancer Res 63:8377\u20138383","journal-title":"Cancer Res"},{"key":"16_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00253-005-0038-2","volume":"70","author":"T Takakura","year":"2006","unstructured":"Takakura T, Ito T, Yagi S, Notsu Y, Itakura T, Nakamura T, Inagaki K, Esaki N, Hoffman RM, Takimoto A (2006) High-level expression and bulk crystallization of recombinant l-methionine \u03b3-lyase, an anticancer agent. Appl Microbiol Biotechnol 70:183\u2013192","journal-title":"Appl Microbiol Biotechnol"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1158\/0008-5472.CAN-05-3910","volume":"66","author":"T Takakura","year":"2006","unstructured":"Takakura T, Takimoto A, Notsu Y, Yoshida H, Ito T, Nagatome H, Ohno M, Kobayashi Y, Yoshioka T, Inagaki K, Yagi S, Hoffman RM, Esaki N (2006) Physicochemical and pharmacokinetic characterization of highly potent recombinant l-methionine \u03b3-lyase conjugated with polyethylene glycol as an antitumor agent. Cancer Res 66:2807\u20132814","journal-title":"Cancer Res"},{"key":"16_CR28","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/jb\/mvm055","volume":"141","author":"D Kudou","year":"2007","unstructured":"Kudou D, Misaki S, Yamashita M, Tamura T, Takakura T, Yoshioka T, Yagi S, Hoffman RM, Takimoto A, Esaki N, Inagaki K et al (2007) J Biochem 141:535\u2013544","journal-title":"J Biochem"},{"key":"16_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ab.2004.01.024","volume":"327","author":"T Takakura","year":"2004","unstructured":"Takakura T, Mitsushima K, Yagi S, Inagaki K, Tanaka H, Esaki N, Soda K, Takimoto A et al (2004) Anal Biochem 327:233\u2013240","journal-title":"Anal Biochem"},{"key":"16_CR30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0021-9673(01)90918-5","volume":"266","author":"BN Jones","year":"1983","unstructured":"Jones BN, Gilligan JP (1983) O-Phthaldialdehyde precolumn derivatization and reversed-phase high-performance liquid chromatography of polypeptide hydrolysates and physiological fluids. J Chromatogr 266:471\u2013482","journal-title":"J Chromatogr"},{"key":"16_CR31","first-page":"4859","volume":"49","author":"JG Judde","year":"1989","unstructured":"Judde JG, Ellis M, Frost P (1989) Biochemical analysis of the role of transmethylation in the methionine dependence of tumor cells. Cancer Res 49:4859\u20134865","journal-title":"Cancer Res"},{"key":"16_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/bjc.1980.210","volume":"42","author":"MJ Tisdale","year":"1980","unstructured":"Tisdale MJ (1980) Effect of methionine deprivation on methylation and synthesis of macromolecules. Br J Cancer 42:121\u2013128","journal-title":"Br J Cancer"},{"key":"16_CR33","first-page":"5676","volume":"53","author":"H Guo","year":"1993","unstructured":"Guo H, Lishko V, Herrera H, Groce A, Kubota T, Hoffman RM (1993) Therapeutic tumor-specific cell-cycle block induced by methionine starvation in vivo. Cancer Res 53:5676\u20135679","journal-title":"Cancer Res"},{"key":"16_CR34","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.1073\/pnas.77.12.7306","volume":"77","author":"RM Hoffman","year":"1980","unstructured":"Hoffman RM, Jacobsen SJ (1980) Reversible growth arrest in simian virus 40-transformed human fibroblasts. Proc Natl Acad Sci U S A 77:7306\u20137310","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR35","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/bjc.1997.141","volume":"75","author":"DM Kokkinakis","year":"1997","unstructured":"Kokkinakis DM, von Wronski MA, Vuong TH, Brent TP, Schold SC Jr (1997) Regulation of O6-methylguanine-DNA methyltransferase by methionine in human tumour cells. Br J Cancer 75:779\u2013788","journal-title":"Br J Cancer"},{"key":"16_CR36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/jnci\/76.4.629","volume":"76","author":"PH Stern","year":"1986","unstructured":"Stern PH, Hoffman RM (1986) Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. J Natl Cancer Inst 76:629\u2013639","journal-title":"J Natl Cancer Inst"},{"key":"16_CR37","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1080\/15384101.2016.1181240","volume":"15","author":"S Yano","year":"2016","unstructured":"Yano S, Takehara K, Zhao M, Tan Y, Han Q, Li S, Bouvet M, Fujiwara T, Hoffman RM (2016) Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging. Cell Cycle 15:1715\u20131723","journal-title":"Cell Cycle"},{"key":"16_CR38","doi-asserted-by":"publisher","first-page":"8729","DOI":"10.18632\/oncotarget.2369","volume":"5","author":"S Yano","year":"2014","unstructured":"Yano S, Li S, Han Q, Tan Y, Bouvet M, Fujiwara T, Hoffman RM (2014) Selective methioninase-induced trap of cancer cells in S\/G2 phase visualized by FUCCI imaging confers chemosensitivity. Oncotarget 5:8729\u20138736","journal-title":"Oncotarget"},{"key":"16_CR39","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1349-7006.1995.tb03082.x","volume":"86","author":"N Goseki","year":"1995","unstructured":"Goseki N, Yamazaki S, Shimojyu K, Kando F, Maruyama M, Endo M, Koike M, Takahashi H (1995) Synergistic effect of methionine-depleting total parenteral nutrition with 5-fluorouracil on human gastric cancer: a randomized, prospective clinical trial. Jpn J Cancer Res 86:484\u2013489","journal-title":"Jpn J Cancer Res"},{"key":"16_CR40","first-page":"6805","volume":"61","author":"K Miki","year":"2001","unstructured":"Miki K, Xu M, Gupta A, Ba Y, Tan Y, Al-Refaie W, Bouvet M, Makuuchi M, Moossa AR, Hoffman RM (2001) Methioninase cancer gene therapy with selenomethionine as suicide prodrug substrate. Cancer Res 61:6805\u20136810","journal-title":"Cancer Res"},{"key":"16_CR41","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.canlet.2017.12.028","volume":"417","author":"K Igarashi","year":"2018","unstructured":"Igarashi K, Kawaguchi K, Li S, Han Q, Tan Y, Murakami T, Kiyuna T, Miyake K, Miyake M, Singh AS, Eckhadt MA, Nelson SD, Russell TA, Dry SM, Li Y, Yamamoto N, Hayashi K, Kimura H, Miwa S, Tsuchiya H, Singh RS, Eilber FC, Hoffman RM (2018) Recombinant methioninase in combination with DOX overcomes first-line DOX resistance in a patient-derived orthotopic xenograft nude-mouse model of undifferentiated spindle-cell sarcoma. Cancer Lett 417:168\u2013173","journal-title":"Cancer Lett"},{"key":"16_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.canlet.2018.06.016","volume":"432","author":"Kei Kawaguchi","year":"2018","unstructured":"Kawaguchi K, Miyake K, Han Q, Li S, Tan Y, Igarashi K, Kiyuna T, Miyake M, Higuchi T, Oshiro H, Zhang Z, Razmjooei S, Wangsiricharoens S, Bowet M, Singh SR, Unnu M, Hoffman RM (2018) Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer. Cancer Lett 432:251\u2013259","journal-title":"Cancer Letters"},{"key":"16_CR43","doi-asserted-by":"publisher","unstructured":"Miyake K, Kiyuna T, Li S, Han Q, Tan Y, Zhao M, Oshiro H, Kawaguchi K, Higuchi T, Zhang Z, Razmjooei S, Barangi M, Wangsiricharoen S, Murakami T, Singh AS, Li Y, Nelson SD, Eilber FC, Bouvet M, Hiroshima Y, Chishima T, Matsuyama R, Singh SR, Endo I, Hoffman RM (in press) Combining tumor-selective bacterial therapy with Salmonella typhimurium A1-R and cancer metabolism targeting with oral recombinant methioninase (o-rMETase) regressed a Ewing\u2019s sarcoma in a PDOX model. Chemotherapy. https:\/\/doi.org\/10.1159\/000495574","DOI":"10.1159\/000495574"},{"key":"16_CR44","doi-asserted-by":"crossref","first-page":"19263","DOI":"10.18632\/oncotarget.24996","volume":"9","author":"K Igarashi","year":"2018","unstructured":"Igarashi K, Kawaguchi K, Li S, Han Q, Tan Y, Gainor E, Kiyuna T, Miyake K, Miyake M, Higuchi T, Oshiro H, Singh AS, Eckardt MA, Nelson SD, Russell TA, Dry SM, Li Y, Yamamoto N, Hayashi K, Kimura H, Miwa S, Tsuchiya H, Eilber FC, Hoffman RM (2018) Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant Dynovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model. Oncotarget 9:19263\u201319272","journal-title":"Oncotarget"},{"key":"16_CR45","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/15384101.2018.1431596","volume":"17","author":"K Igarashi","year":"2019","unstructured":"Igarashi K, Kawaguchi K, Kiyuna T, Miyake K, Miyake M, Li S, Han Q, Tan Y, Zhao M, Li Y, Nelson SD, Dry SM, Singh AS, Elliott IA, Russell TA, Eckardt MA, Yamamoto N, Hayashi K, Kimura H, Miwa S, Tsuchiya H, Eilber FC, Hoffman RM (2019) Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic. Cell Cycle 17:801\u2013809","journal-title":"Cell Cycle"}],"container-title":["Methods in Molecular Biology","Methionine Dependence of Cancer and Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-8796-2_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T22:13:49Z","timestamp":1606428829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-8796-2_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493987955","9781493987962"],"references-count":45,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-8796-2_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"7 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}